Peptides, peptide combinations, and cell based drugs for use in immunotherapy against bladder cancer and other cancers

摘要

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapy. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to a tumor associated T cell peptide epitope alone or in combination with other tumor associated peptides, which for example stimulates an anti-tumor immune response or stimulates T cells ex vivo to patients And act as the active pharmaceutical ingredient of the vaccine composition. Peptides bound to molecules of the major histocompatibility complex (MHC), or the peptides themselves, can also be targets for antibodies, soluble T cell receptors, and other binding molecules.